Goethe University Frankfurt am Main (GU)

Professorship (W2) for Tumor Immunology supported by Merck KgaA

Medical Faculty of the Johann Wolfgang Goethe-University Frankfurt am Main

Frankfurt am Main, Germany

The Medical Faculty of the Johann Wolfgang Goethe-University Frankfurt am Main invites applications for the following position at the “Frankfurt Cancer Institute – Molecular Mechanisms of Therapy Response to Tumor Diseases and Development of Individual Tumor Therapies” as civil servant or public employee, initially limited for six years:

Professorship (W2) for Tumor Immunology supported by Merck KgaA

The ""Frankfurt Cancer Institute"" (FCI) is funded by the state of Hesse as part of the Landesoffensive for the Development of Scientific and Economic Excellence (LOEWE) and aims to elucidate molecular mechanisms of pathophysiology and treatment response to cancer by using an intelligent combination of molecular profiling, mechanistic research and clinical evaluation. Partners in the center are the scientific and clinical departments of the Medical Faculty of the Goethe University Frankfurt am Main, the Georg Speyer Haus – Institute for Tumor Biology and Experimental Therapy, the Max Planck Institute for Heart and Lung Research in Bad Nauheim and the Paul Ehrlich Institute in Langen. Further information on the LOEWE Center ""Frankfurt Cancer Institute"" can be found at www.fci.health. The professorship is located at the Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy (Director: Prof. Dr. Florian R. Greten, www.georg-speyer-haus.de).

We are looking for a scientist with internationally proven experience and outstanding research and teaching performance in the field of tumor immunology with focus on T-cell immunology. The applicant is expected to have performed excellent research in the area of tumor immunology, e.g. on molecular and cellular mechanisms on response and relapse in malignant disease or experience in the development of innovative immune therapeutic concepts.

Prerequisite for the application is a university degree, doctorate and habilitation or proof of equivalent scientific achievements. The applicant is expected to have an excellent scientific record with international publication performance, proof of effective and modern teaching and continuing education experience and a high degree of scientific commitment. In addition, the applicant is expected to participate in the interdisciplinary structure of the FCI and to add a high level of cooperation with all working groups of the FCI, especially in the interdisciplinary cross-sectional programs.

The salary for the position is based on “W2” on the German university scale, including performance bonuses that are object of negotiation. Goethe University is committed to increasing the proportion of female faculty and therefore especially encourages women to apply. Applications of scientists from abroad are explicitly requested. Severely disabled applicants with equal qualification and aptitude will be given preferential consideration. For further information regarding the general conditions for professorship appointments, please see: www.vakante-professuren.uni-frankfurt.de

Researchers with an excellent record in research and teaching are invited to submit their application (including a CV, complete list of publications, list of courses held and, if applicable, teaching evaluations), written in accordance with the guidelines of the Medical Faculty (preferably as a single pdf document) until 4 December 2019 to the Dean of the Medical Faculty of Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, e-mail: Bewerbungen-Professur4@kgu.de. Application documents will not be returned after the procedure has been completed. Specific application guidelines can be found at: http://www.uni-frankfurt.de/60005087/berufungen

Favorite

Apply with CV and Cover Letter

Must be a .doc, .docx, or .pdf file and no larger than 1MBMust be a .doc, .docx, or .pdf file and no larger than 1MB
Position

Professorship (W2) for Tumor Immunology supported by Merck KgaA